KINNATE BIOPHARMA INC's ticker is KNTE and the CUSIP is 49705R105. A total of 78 filers reported holding KINNATE BIOPHARMA INC in Q1 2022. The put-call ratio across all filers is - and the average weighting 1.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $88,144 | +4.5% | 14,103 | +2.0% | 0.00% | 0.0% |
| Q4 2022 | $84,314 | -49.2% | 13,822 | -0.4% | 0.00% | 0.0% |
| Q3 2022 | $166,000 | -3.5% | 13,872 | +1.4% | 0.00% | 0.0% |
| Q2 2022 | $172,000 | +19.4% | 13,677 | +7.0% | 0.00% | 0.0% |
| Q1 2022 | $144,000 | -40.5% | 12,778 | -6.6% | 0.00% | 0.0% |
| Q4 2021 | $242,000 | -25.3% | 13,678 | -2.9% | 0.00% | -50.0% |
| Q3 2021 | $324,000 | +83.1% | 14,087 | +85.4% | 0.00% | +100.0% |
| Q2 2021 | $177,000 | -27.8% | 7,598 | -3.5% | 0.00% | 0.0% |
| Q1 2021 | $245,000 | – | 7,877 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Foresite Capital Management IV, LLC | 9,671,643 | $384,738,000 | 41.79% |
| Foresite Capital Management V, LLC | 875,001 | $34,808,000 | 25.78% |
| Vida Ventures Advisors, LLC | 2,747,074 | $109,279,000 | 22.43% |
| VR Adviser, LLC | 1,473,014 | $58,596,000 | 8.62% |
| RA Capital Management | 3,593,052 | $142,932,000 | 2.00% |
| Logos Global Management LP | 569,602 | $22,659,000 | 1.94% |
| Boxer Capital, LLC | 1,064,665 | $42,352,000 | 1.36% |
| Orbimed Advisors | 3,847,929 | $153,071,000 | 1.34% |
| HARVARD MANAGEMENT CO INC | 498,001 | $19,810,000 | 1.07% |
| DAFNA Capital Management LLC | 68,121 | $2,710,000 | 0.81% |